By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

European Commission (EC) 

Rue Joseph II
Jozef II straat 70
Brussels    B-1000  Belgium
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
Recordati: The European Commission (EC) Approves Reagila (Cariprazine) For The Treatment Of Schizophrenia 7/19/2017 11:03:39 AM
European Commission (EC) Accuses Teva (TEVA), Cephalon (CEPH) of Anti-Competitive Behavior 7/17/2017 6:04:08 AM
European Commission (EC) Approves Almirall’s Skilarence For Moderate-To-Severe Chronic Plaque Psoriasis 6/28/2017 10:15:42 AM
European Commission (EC) Approves Bristol-Myers Squibb (BMY)’s Opdivo (Nivolumab) For Previously Treated Locally Advanced Unresectable Or Metastatic Urothelial Carcinoma In Adults After Failure Of Prior Platinum-Containing Therapy 6/5/2017 12:05:33 PM
BioMarin (BMRN) Release: European Commission (EC) Approves Brineura (Cerliponase Alfa), The First Treatment For CLN2 Disease, A Form Of Batten Disease And Ultra-Rare Brain Disorder In Children 6/1/2017 6:59:47 AM
European Commission (EC) Approves Pfizer (PFE)’s TRUMENBA To Help Prevent Meningococcal Group B Disease In Adolescents And Adults 5/30/2017 8:29:59 AM
European Commission (EC) Approves EUSA Pharma’s Dinutuximab Beta For The Treatment Of Patients With High-Risk Neuroblastoma 5/10/2017 8:51:17 AM
Merck & Co. (MRK) Release: European Commission (EC) Approves KEYTRUDA (Pembrolizumab) For Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma Who Failed Autologous Stem Cell Transplant And Brentuximab Vedotin (BV), Or Who Are Transplant-Ineligible And Have Failed BV 5/5/2017 6:09:53 AM
European Commission (EC) Approves Bristol-Myers Squibb (BMY)’s Opdivo (Nivolumab) For Squamous Cell Cancer Of The Head And Neck In Adults Progressing On Or After Platinum-Based Therapy 5/1/2017 7:09:46 AM
European Commission (EC) Extends Approval For Janssen-Cilag International NV (JNJ)’s DARZALEX (Daratumumab) To Include Multiple Myeloma Patients Who Have Received At Least One Prior Therapy 4/28/2017 6:21:57 AM
12345678910...
//-->